Episurf Medical AB (publ) (STO:EPIS.B)

Sweden · Delayed Price · Currency is SEK

0.0570

+0.0011 (1.97%)

Jul 24, 2026, 5:24 PM CET

Episurf Medical AB Financials Overview

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	25.1	22.8	20.7	20.1	18.2	13.8
Revenue Growth	30.05%	10.14%	2.99%	10.44%	31.88%	97.14%
Gross Profit	17.6	12.7	10.8	12.8	14	9
Operating Income	-66.5	-57.9	-77.2	-96.7	-77	-69.4
Net Income	-68.5	-58.2	-76	-94.8	-77.3	-69.3
Earnings Per Share	-0.06	-0.06	-0.16	-0.40	-0.30	-0.30
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Germany	5.1	6.1	6.1	4.4	4.3
US	3.3	2.7	0.4	-	-
Nordic	0.4	0.6	0.7	0.5	0.2
Other Countries in Europe	4.5	3.2	2.8	1.5	1.8
Other Countries outside of Europe	0.2	0.3	0.4	0.1	0.1
Total	13.5	12.9	10.4	6.5	6.4

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	12.2	2.4	50.5	57.9	155.3	237.9
Total Debt	48.4	0	2.3	5.4	7.3	5.7
Net Cash (Debt)	-36.2	2.4	48.2	52.5	148	232.2
Net Cash Growth	-	-95.02%	-8.19%	-64.53%	-36.26%	54.29%
Net Cash Per Share	-0.03	0.00	0.10	0.20	0.56	1.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-28.8	-55.3	-71.4	-84.8	-69.5	-59.7
Capital Expenditures	-0.2	-	-	0	0	-0.1
Free Cash Flow	-29	-55.3	-71.4	-84.8	-69.5	-59.8
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	70.12%	55.70%	52.17%	63.68%	76.92%	65.22%
Operating Margin	-264.94%	-253.95%	-372.95%	-481.10%	-423.08%	-502.90%
Pretax Margin	-272.51%	-254.39%	-367.15%	-470.65%	-424.18%	-501.45%
Profit Margin	-272.91%	-255.70%	-367.63%	-472.14%	-424.73%	-501.45%
FCF Margin	-115.54%	-242.54%	-344.93%	-421.89%	-381.87%	-433.33%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	9.58	2.70	2.93	8.97	23.46	59.87